← Leaderboards
Mohamed Abdel Mohsen
Wistar Institute
$12,661,177
Attributed
$23,963,729
Total exposure
17
Grants
12
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $4.8M · FY2017–25$5M$3.8M$2.5M$1.3M$0
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$23,963,729 · 17
By mechanism
R01$19,925,780 · 8
R21$2,526,969 · 5
R56$1,194,045 · 2
P30$316,935 · 2
Top collaborators
- Ali Keshavarzian12 shared
- Alan L Landay6 shared
- Lishomwa C Ndhlovu6 shared
- Han Xiao6 shared
- Nadia R Roan5 shared
- David J Volsky4 shared
- Todd T Brown1 shared
- Emmanouil Papasavvas1 shared
Most similar at Wistar Institute
Same institution · by research overlap
- Ali Keshavarzian$17,414,525
- Alan L Landay$11,728,289
- Emmanouil Papasavvas$200,705
Others in their field
Other Emerging Leaders on “Antiretroviral Therapy”
- Yunda Huang · Fred Hutchinson Cancer Center$52,003,716
- Marlene Ann Cooper · Harvard University D/B/A Harvard School Of Public Health$29,616,650
- Wendy Sammons-Jackson · National Institute Of Allergy And Infectious Diseases$29,269,420
- Jacob D Estes · Oregon Health & Science University$15,457,863
- Wilton B Williams · Duke University$15,417,829
- Sara Gianella Weibel · University Of California, San Diego$10,528,478
Research focus
Antiretroviral TherapyMediatingHiv InfectionsInflammationLinkPolysaccharidesCarbohydratesPreventPlasmaViralStructureGlycosylationImmune ActivationChronicSialic AcidsCellsBindingSamplingNovel StrategiesPatternComorbidityNeuraminidaseVirusInflammatory
Grant awards (44)
Estrogen's Impact on IgG Glycomic Modulation of Immunity and Inflammation During HIV$2,461,651
R01 · FY2025 · AI
Gut Microbiota-Mediated Inflammatory Interactions Between Alcohol Use Disorders and HIV Infection$720,080
R01 · FY2025 · AA
Targeting Siglec-9/Sialoglycan Interactions to Enhance NK Functions During HIV Infection$608,916
R01 · FY2025 · AI · contact PI
Glycomic Modulation of Inflammaging and Immune Functions during HIV Infection$527,129
R01 · FY2025 · AG · contact PI
Targeting CD127-expressing tissue reservoir cells as a strategy for HIV cure$252,348
R21 · FY2025 · AI
Virology and Immunology Technology Core$219,686
P30 · FY2025 · AI · contact PI
Glycomic Modulation of Gut Microbiome During HIV Infection$802,821
R01 · FY2024 · DK · contact PI
STudy of Acute HIV for investiGating Eradication Strategies (STAGES)$794,045
R56 · FY2024 · AI
Gut Microbiota-Mediated Inflammatory Interactions Between Alcohol Use Disorders and HIV Infection$718,494
R01 · FY2024 · AA
Targeting Siglec-9/Sialoglycan Interactions to Enhance NK Functions During HIV Infection$408,072
R01 · FY2024 · AI · contact PI
Glycomic Modulation of Inflammaging and Immune Functions during HIV Infection$400,000
R56 · FY2024 · AG · contact PI
Targeting Siglec-9/Sialoglycan Interactions to Enhance NK Functions During HIV Infection$270,230
R01 · FY2024 · AI · contact PI
Targeting CD127-expressing tissue reservoir cells as a strategy for HIV cure$250,791
R21 · FY2024 · AI
Host Glycomic Modulation of HIV-associated Neuro-inflammation During Viral Suppression$843,815
R01 · FY2023 · NS · contact PI
Glycomic Modulation of Gut Microbiome During HIV Infection$815,931
R01 · FY2023 · DK · contact PI
Gut Microbiota-Mediated Inflammatory Interactions Between Alcohol Use Disorders and HIV Infection$739,324
R01 · FY2023 · AA
Targeting Siglec-9/Sialoglycan Interactions to Enhance NK Functions During HIV Infection$633,402
R01 · FY2023 · AI · contact PI
Sialic Acid Modulation of HIV-associated Chronic Inflammaging$504,311
R01 · FY2023 · AG · contact PI
Single-cell Analysis of Glycomic and Proteomic Features of the HIV Reservoir$231,225
R21 · FY2023 · AI · contact PI
Microbiota-Mediated Bidirectional Interactions Between Alcohol Misuse and Post-COVID-19 Syndrome$207,052
R01 · FY2023 · AA
Host Glycomic Modulation of HIV-associated Neuro-inflammation During Viral Suppression$847,023
R01 · FY2022 · NS · contact PI
Glycomic Modulation of Gut Microbiome During HIV Infection$803,280
R01 · FY2022 · DK · contact PI
Targeting Siglec-9/Sialoglycan Interactions to Enhance NK Functions During HIV Infection$607,040
R01 · FY2022 · AI · contact PI
Sialic Acid Modulation of HIV-associated Chronic Inflammaging$506,186
R01 · FY2022 · AG · contact PI
Impact of Sex on Glycosylation-dependent Antibody-mediated Innate Immune Functions During HIV Infection$414,160
R01 · FY2022 · AG · contact PI
Single-cell Analysis of Glycomic and Proteomic Features of the HIV Reservoir$298,380
R21 · FY2022 · AI · contact PI
Microbiota-Mediated Bidirectional Interactions Between Alcohol Misuse and Post-COVID-19 Syndrome$208,746
R01 · FY2022 · AA
Host Glycomic Modulation of HIV-associated Neuro-inflammation During Viral Suppression$843,928
R01 · FY2021 · NS · contact PI
Glycomic Modulation of Gut Microbiome During HIV Infection$806,565
R01 · FY2021 · DK · contact PI
Targeting Siglec-9/Sialoglycan Interactions to Enhance NK Functions During HIV Infection$616,815
R01 · FY2021 · AI · contact PI
Sialic Acid Modulation of HIV-associated Chronic Inflammaging$531,851
R01 · FY2021 · AG · contact PI
Microbiota-Mediated Bidirectional Interactions Between Alcohol Misuse and Post-COVID-19 Syndrome$215,870
R01 · FY2021 · AA
Host Glycomic Modulation of HIV-associated Neuro-inflammation During Viral Suppression$907,453
R01 · FY2020 · NS · contact PI
Glycomic Modulation of Gut Microbiome During HIV Infection$849,645
R01 · FY2020 · DK · contact PI
Sialic Acid Modulation of HIV-associated Chronic Inflammaging$517,000
R01 · FY2020 · AG · contact PI
Role of Intestinal Barrier Integrity in Modulating the Host Glycome During COVID-19$456,773
R01 · FY2020 · DK · contact PI
Host Glycomic Determinants of HIV Persistence in vivo$223,250
R21 · FY2020 · AI · contact PI
NADC Supplement$97,249
P30 · FY2020 · CA · contact PI
Sialic Acid Modulation of HIV-associated Chronic Inflammaging$532,217
R01 · FY2019 · AG · contact PI
Host Glycomic Determinants of HIV Persistence in vivo$267,900
R21 · FY2019 · AI · contact PI
Role of Host Glycosylation in the Galectin-9-Mediated Reversal of HIV Latency$212,900
R21 · FY2018 · AI · contact PI
Exploring Cell-free Glycomic Interactions in HIV-associated Neurological Disorders$211,425
R21 · FY2018 · NS · contact PI
Exploring Cell-free Glycomic Interactions in HIV-associated Neurological Disorders$295,850
R21 · FY2017 · NS · contact PI
Role of Host Glycosylation in the Galectin-9-Mediated Reversal of HIV Latency$282,900
R21 · FY2017 · AI · contact PI